Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Bruns, Heiko

Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. [electronic resource] - The Journal of clinical investigation May 2009 - 1167-77 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1558-8238

10.1172/JCI38482 doi


Adult
Antibodies, Monoclonal--metabolism
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--metabolism
Autoimmune Diseases--therapy
Blood Cell Count
CD8-Positive T-Lymphocytes--cytology
Complement System Proteins--immunology
Cytotoxicity, Immunologic--immunology
Female
Humans
Immunity, Cellular--immunology
Immunotherapy--adverse effects
Infliximab
Interferon-gamma--metabolism
Leukocytes, Mononuclear--immunology
Male
Middle Aged
Monocytes--immunology
Mycobacterium tuberculosis--immunology
Perforin
Pore Forming Cytotoxic Proteins--metabolism
T-Lymphocyte Subsets--cytology
Tuberculosis--immunology
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Vesicular Transport Proteins--metabolism